Abstract:Since the identification of four different pancreatic β-cell subtypes and bi-hormomal cells playing a role in the diabetes pathogenesis, the search for in vitro models that mimics such cells heterogeneity became a key priority in experimental and clinical diabetology. We investigated the potential of human induced pluripotent stem cells to lead to the development of the different β-cells subtypes in honeycomb microwell-based 3D spheroids. The glucose-stimulated insulin secretion confirmed the spheroids functionality. Then, we performed a single cell RNA sequencing of the spheroids. Using a knowledge-based analysis with a stringency on the pancreatic markers, we extracted the β-cells INS+/UCN3+ subtype (11%; β1-like cells), the INS+/ST8SIA1+/CD9- subtype (3%, β3-like cells) and INS+/CD9+/ST8SIA1-subtype (1%; β2-like cells) consistently with literature findings. We did not detect the INS+/ST8SIA1+/CD9+ cells (β4-like cells). Then, we also identified four bi-hormonal cells subpopulations including δ-like cells (INS+/SST+, 6%), γ-like cells (INS+/PPY+, 3%), α-like-cells (INS+/GCG+, 6%) and ε-like-cells (INS+/GHRL+, 2%). Using data-driven clustering, we extracted four progenitors' subpopulations (with the lower level of INS gene) that included one population highly expressing inhibin genes (INHBA+/INHBB+), one population highly expressing KCNJ3+/TPH1+, one population expressing hepatocyte-like lineage markers (HNF1A+/AFP+), and one population expressing stem-like cell pancreatic progenitor markers (SOX2+/NEUROG3+). Furthermore, among the cycling population we found a large number of REST+ cells and CD9+ cells (CD9+/SPARC+/REST+). Our data confirm that our differentiation leads to large β-cell heterogeneity, which can be used for investigating β-cells plasticity under physiological and pathophysiological conditions.

In depth functional characterization of human induced pluripotent stem cell-derived beta cells in vitro and in vivo

In Vitro Expansion of Pancreatic Islet Clusters Facilitated by Hormones and Chemicals.

Differentiation of Sendai Virus-Reprogrammed iPSC into β Cells, Compared with Human Pancreatic Islets and Immortalized β Cell Line

Generation of β-like cell subtypes from differentiated human induced pluripotent stem cells in 3D spheroids

Applications of iPSC-derived beta cells from patients with diabetes

Differentiation and Transplantation of Functional Pancreatic Beta Cells Generated from Induced Pluripotent Stem Cells Derived from a Type 1 Diabetes Mouse Model

Recent advances and potential applications of human pluripotent stem cell-derived pancreatic cells

Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells

Transcriptome Analysis of Induced Pluripotent Stem Cell (iPSC)-derived Pancreatic β-like Cell Differentiation

Differentiation of human pluripotent stem cells into β-cells: Potential and challenges

Highly Efficient Differentiation of Human ES Cells and Ips Cells into Mature Pancreatic Insulin-Producing Cells

In Vivo And In Vitro Characterization Of Insulin-Producing Cells Obtained From Murine Bone Marrow

Forward programming of hiPSCs towards beta-like cells using Ngn3, Pdx1, and MafA

In vitro derivation of functional insulin-producing cells from human embryonic stem cells

Chemical Combinations Potentiate Human Pluripotent Stem Cell-Derived 3D Pancreatic Progenitor Clusters Toward Functional Β Cells

Comparative Study on the Proliferation and Differentiation of Fetal and Adult Human Islet-derived Precursor Cells in vitro

Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control

Acquisition of Dynamic Function in Human Stem Cell-Derived β Cells

Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes

Generation of human iPSC-derived pancreatic organoids to study pancreas development and disease

Stepwise Differentiation of Functional Pancreatic Β Cells from Human Pluripotent Stem Cells